Thursday, May 7, 2026
5:30 PM – 6:30 PM UTC
1:30 PM – 2:30 PM EDT
7:30 PM – 8:30 PM CEST
Learning Objectives:
-
Enhance understanding of CINV classification—acute, delayed, and anticipatory types—along with their pathophysiology and variability in patient experiences
-
Emphasize the importance of proactive management for highly emetogenic agents
-
Raise awareness of antiemetic guidelines and evidence-based best practices for effective CINV prevention and management
-
Promote collaboration within multidisciplinary teams to improve CINV management strategies and advance patient care outcomes
-
Gain valuable insights into patients’ experiences to better understand the personal and emotional impact of delayed nausea, as well as barriers to effective symptom control
Agenda:
- Introduction – Prof. Maryam Lustberg (Chair)
- Understanding CINV: Pathophysiology, Risk Factors & Patient Variability – Dr. George Dranitsaris
- Best Practices in CINV Prophylaxis: Integrating Guidelines & MDT Strategies – Dr. Rudolph M. Navari
- The Patient Perspective: Living with Delayed Nausea – Abigail Johnston, JD (Patient Partner)
- Q & A
Speakers:
Dr. Maryam Lustberg
(Chair)
Dr. George Dranitsaris
Dr. Rudolph M. Navari
Abigail Johnston, JD
(Patient Partner)
This webinar is supported by an independent educational grant from Daiichi Sankyo
